| Financial Year |
March 31 2023 |
| Monetary Funds |
2,218,772,030.34 |
| Held-for-trading Financial Assets |
40,031,369.86 |
| Notes Receivable |
42,538,487.39 |
| Accounts Receivable |
1,339,700,161.19 |
| Advances to Suppliers |
214,097,084.94 |
| Other Receivables |
78,599,164.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,339,988,870.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
9,947,294.23 |
| Other Current Assets |
204,657,708.99 |
| Total Current Assets |
7,931,545,495.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,875,009.42 |
| Long-term Equity Investment |
76,461,510.16 |
| Investment Properties |
122,051,146.06 |
| Fixed Assetes |
655,674,167.85 |
| Under-construction Projects |
178,655,811.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
111,200,771.62 |
| R&D expenses |
31,414,461.36 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,268,403.56 |
| Deferred Income Tax Assets |
58,485,819.36 |
| Other Non-Current Assets |
163,636,415.42 |
| Sub-Total of Non-Current Assets |
1,750,393,129.84 |
| Total Assets |
9,681,938,625.10 |
| Short-Term Loans |
266,970,581.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,725,516.08 |
| Accounts Payable |
1,584,335,457.90 |
| Accounts Received In Advance |
4,097,560.52 |
| Employee Compensation Payable |
217,507,864.22 |
| Taxes Payable |
48,226,113.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
155,111,466.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,304,814.65 |
| Other Current Liabilities |
8,664,623.84 |
| Sub-Total of Current Liabilities |
4,870,170,695.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
81,610,811.48 |
| Deferred Income Tax Liabilities |
17,885,667.03 |
| Other Non-Current Liabilities |
31,797,002.19 |
| Sub-Total of Non-Current Liabilities |
170,142,531.76 |
| Total Liabilities |
5,040,313,227.03 |
| Paid-In Capital(Or Share Stock) |
1,340,727,007.00 |
| Capital Surplus |
1,156,858,010.20 |
| Surplus Reserve |
77,248,321.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,656,250,000.54 |
| Minority Stockholder's Interest |
415,687,800.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,225,937,597.99 |
| Owner's Equity（Stockholder's Equity） |
4,641,625,398.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,681,938,625.10 |
